Translational individualised medicine: inflammation and cancer
2023 Activity indicators
- 1 national competitive public project led: ISCIII
- 2 private projects led
- 45 publications
- IF: 238.46
- Q1 publications: 22 (49%)
- D1 publications: 9 (20%)
- 1 thesis
- 1 award
- Evaluators of public research agencies: 2 PI.
- Members of editorial committees: 1 PI.
Milestones
-
Consolidation of the MITIC-CM Consortium of the Biomedicine R&D Activities Programmes of the Community of Madrid (B2022/BMD-7321).
-
Miguel Ángel Ortega et al. A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities. Mil Med Res. 2023 Jun 9;10(1):26. doi: 10.1186/s40779-023-00461-z. PMID: 37291666
-
Defended doctoral thesis of a young clinical researcher with quality ratings and 5 publications in JCR.
-
Implementation of the University Chair for Research on the Central Nervous System (ADAMED).
-
Intense sponsorship activities with more than half a million euros in clinical and translational research.
Bibliometrics
| ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
|---|---|---|---|---|---|---|---|
| 2019 | 12 | 58.56 | 4.88 | 10 | 83 | 2 | 17 |
| 2020 | 14 | 59.21 | 4.23 | 13 | 93 | 1 | 7 |
| 2021 | 40 | 174.69 | 4.48 | 34 | 85 | 4 | 10 |
| 2022 | 49 | 307.13 | 6.27 | 42 | 86 | 3 | 6 |
| 2023 | 45 | 238.46 | 5.55 | 38 | 84 | 9 | 20 |
| 160 | 838.05 | 5.08 | 137 | 86 | 19 | 12 |
